Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition (Q40757720)

23 September 2017

title

Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition (English)

1 reference

23 September 2017

1 reference

6

Marie-Agnès Dillies

1 reference

23 September 2017

0 references

Matthieu Galtier

1

1 reference

23 September 2017

Luisa De Sordi

2

1 reference

23 September 2017

Damien Maura

3

1 reference

23 September 2017

Harindra Arachchi

4

1 reference

23 September 2017

Stevenn Volant

5

1 reference

23 September 2017

Laurent Debarbieux

7

1 reference

23 September 2017

publication date

11 March 2016

1 reference

Environmental Microbiology

23 September 2017

published in

1 reference

23 September 2017

volume

18

1 reference

23 September 2017

issue

7

1 reference

23 September 2017

page(s)

2237-2245

1 reference

Phage treatment of human infections.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Phenotypic and genotypic assays for the detection and identification of adhesins from pyelonephritic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Bacterial sensing of bacteriophages in communities: the search for the Rosetta stone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia With Bacteriophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Effects of antibiotics on human microbiota and subsequent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Intestinal colonization by enteroaggregative Escherichia coli supports long-term bacteriophage replication in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Rapid evolution of the human gut virome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Host-gut microbiota metabolic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Escherichia coli ST131, an intriguing clonal group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Disease-specific alterations in the enteric virome in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Maternally acquired genotoxic Escherichia coli alters offspring's intestinal homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Relative fecal abundance of extended-spectrum-β-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Control of brain development, function, and behavior by the microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

A randomized clinical trial to evaluate the preventive effect of cranberry juice (UR65) for patients with recurrent urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Analysis of 16S rRNA amplicon sequencing options on the Roche/454 next-generation titanium sequencing platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Infection control in the multidrug-resistant era: tending the human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Uropathogenic Escherichia coli mediated urinary tract infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

MicroScope--an integrated microbial resource for the curation and comparative analysis of genomic and metabolic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

MICROBIOLOGY. Phage therapy redux--What is to be done?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

The management of urinary infections; what have we learned in the past decade?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

21 January 2018

Identifiers

DOI

10.1111/1462-2920.13284

1 reference

release_zpxfvq5lynf5zjgo2ona2n5bky

23 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zpxfvq5lynf5zjgo2ona2n5bky

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference